XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Long-Term Investments (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 10, 2019
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Long-Term Investments (Details) [Line Items]        
Percentage of common stock shares 70.00%      
Purchase additional shares (in Shares)   317,000 317,000  
Additional shares issued (in Shares)   75,000    
Prepayment for long-term investments (in Dollars)   $ 663,798 $ 684,720
BioFirst [Member]        
Long-Term Investments (Details) [Line Items]        
Percentage of common stock shares   15.99% 15.99% 15.99%
Additional shares issued (in Shares)   663,798 684,720  
Sale of common stock, description       the Company sold 218,000 shares of common stock of BioHopeKing Corporation at price of NT$24, equivalent $0.85, to several individuals, and the percentage of ownership decreased to 5.90% as of December 31, 2020. As a result of the transactions, the Company recognized investment loss of $40,589 and impairment loss of $961,217 for the year ended December 31, 2020.
Rgene [Member]        
Long-Term Investments (Details) [Line Items]        
Percentage of common stock shares   31.62% 31.62% 31.62%